Authors: Diep PT, Buemann B, Uvnas-Moberg K

PMID: 34908992 PMCID: PMC8629037 DOI: 10.36131/CNEPUB20201703


After comparing the morbidity patterns of COVID-19 infections, variations of oxytocin levels and some properties of the neurohormone oxytocin, the authors put forward their hypothesis that oxytocin might constitute a safe, inexpensive and readily available treatment for this disease.

Keywords: COVID-19, pandemic; immune system; inflammation; oxytocin; treatment.